NCT05553145View on ClinicalTrials.gov

The Prevalence of Autoimmune Antibodies in Patients with Type 2 Diabetes Managed by Endocrinology Vs. Primary Care

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

September 1, 2022

Primary Completion Date

May 31, 2023

Study Completion Date

August 29, 2024

Conditions
Type 2 Diabetes
Interventions
DIAGNOSTIC_TEST

Autoimmune Antibody Assays

GAD-65, Islet cell-Ab, IA-2 Ab, anti-insulin Ab, and ZnTn8 Ab

Trial Locations (1)

44087

Twinsburg Family Health & Surgery Center, Twinsburg

All Listed Sponsors
lead

The Cleveland Clinic

OTHER